Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines

6 Feb 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genetic factors in colorectal cancer
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30725392
DOI: 10.1007/s12282-019-00951-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesPMID 30725392Read ↗

[China expert consensus on BRCA variant interpretation].Semantic proximity Read ↗

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.Semantic proximity Read ↗

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.Semantic proximity Read ↗

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.Semantic proximity Read ↗

Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.Semantic proximity Read ↗

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.Semantic proximity Read ↗

BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.Semantic proximity Read ↗

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.Semantic proximity Read ↗

Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.Semantic proximity Read ↗

Changes in classification of genetic variants in BRCA1 and BRCA2.Semantic proximity Read ↗

Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.Semantic proximity Read ↗

BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.